Eileen Jaracz

1.1k total citations
16 papers, 756 citations indexed

About

Eileen Jaracz is a scholar working on Dermatology, Immunology and Allergy and Epidemiology. According to data from OpenAlex, Eileen Jaracz has authored 16 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Dermatology, 11 papers in Immunology and Allergy and 3 papers in Epidemiology. Recurrent topics in Eileen Jaracz's work include Dermatology and Skin Diseases (14 papers), Allergic Rhinitis and Sensitization (11 papers) and Food Allergy and Anaphylaxis Research (5 papers). Eileen Jaracz is often cited by papers focused on Dermatology and Skin Diseases (14 papers), Allergic Rhinitis and Sensitization (11 papers) and Food Allergy and Anaphylaxis Research (5 papers). Eileen Jaracz collaborates with scholars based in United States, United Kingdom and France. Eileen Jaracz's co-authors include Alan B. Fleischer, M. Joyce Rico, Lawrence F. Eichenfield, Toni Shull, Amy S. Paller, William Abramovits, Debra Breneman, Robert S. Kirsner, Jon M. Hanifin and Michael H. Gold and has published in prestigious journals such as PEDIATRICS, Journal of the American Academy of Dermatology and Value in Health.

In The Last Decade

Eileen Jaracz

16 papers receiving 709 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eileen Jaracz United States 14 681 537 105 77 62 16 756
Nathalie Barbier Switzerland 11 748 1.1× 627 1.2× 52 0.5× 145 1.9× 52 0.8× 19 832
Zbigniew Samochocki Poland 14 423 0.6× 268 0.5× 32 0.3× 125 1.6× 92 1.5× 36 553
Jeremy Udkoff United States 10 324 0.5× 244 0.5× 72 0.7× 89 1.2× 34 0.5× 27 420
Michelle Tarbox United States 7 367 0.5× 193 0.4× 31 0.3× 71 0.9× 71 1.1× 77 506
Ann Broberg Sweden 9 366 0.5× 267 0.5× 116 1.1× 114 1.5× 32 0.5× 14 472
Claudia Jenneck Germany 6 518 0.8× 450 0.8× 20 0.2× 226 2.9× 159 2.6× 7 748
Matthias Braeutigam Germany 8 269 0.4× 125 0.2× 62 0.6× 29 0.4× 65 1.0× 9 328
Natalija Novak Germany 14 651 1.0× 599 1.1× 22 0.2× 307 4.0× 196 3.2× 21 881
Murlidhar Rajagopalan India 11 452 0.7× 100 0.2× 84 0.8× 49 0.6× 116 1.9× 20 617
May E. Venturanza United States 9 382 0.6× 302 0.6× 15 0.1× 89 1.2× 50 0.8× 33 453

Countries citing papers authored by Eileen Jaracz

Since Specialization
Citations

This map shows the geographic impact of Eileen Jaracz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen Jaracz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen Jaracz more than expected).

Fields of papers citing papers by Eileen Jaracz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eileen Jaracz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen Jaracz. The network helps show where Eileen Jaracz may publish in the future.

Co-authorship network of co-authors of Eileen Jaracz

This figure shows the co-authorship network connecting the top 25 collaborators of Eileen Jaracz. A scholar is included among the top collaborators of Eileen Jaracz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eileen Jaracz. Eileen Jaracz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Roberts, Janet L., Jean‐Paul Ortonne, Jerry Tan, Eileen Jaracz, & Ellen Frankel. (2010). The safety profile and sustained remission associated with response to multiple courses of intramuscular alefacept for treatment of chronic plaque psoriasis. Journal of the American Academy of Dermatology. 62(6). 968–978. 12 indexed citations
2.
Paller, Amy S., Lawrence F. Eichenfield, Robert S. Kirsner, et al.. (2008). Three Times Weekly Tacrolimus Ointment Reduces Relapse in Stabilized Atopic Dermatitis: A New Paradigm for Use. PEDIATRICS. 122(6). e1210–e1218. 59 indexed citations
3.
Breneman, Debra, Alan B. Fleischer, William Abramovits, et al.. (2008). Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: A randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle. Journal of the American Academy of Dermatology. 58(6). 990–999. 79 indexed citations
4.
Jaracz, Eileen, et al.. (2008). PSS18 COST-EFFECTIVENESS OF THE BIOLOGIC AGENTS UTILIZED IN THE TREATMENT OF CHRONIC PLAQUE PSORIASIS: A MARKOV MODEL. Value in Health. 11(3). A289–A290. 1 indexed citations
5.
Abramovits, William, Alan B. Fleischer, Eileen Jaracz, & Debra Breneman. (2008). Adult patients with moderate atopic dermatitis: tacrolimus ointment versus pimecrolimus cream.. PubMed. 7(12). 1153–8. 19 indexed citations
6.
Cather, Jennifer Clay, et al.. (2007). Alefacept revisited: Our 3-year clinical experience in 200 patients with chronic plaque psoriasis. Journal of the American Academy of Dermatology. 58(1). 116–124. 17 indexed citations
7.
Fleischer, Alan B., William Abramovits, Debra Breneman, & Eileen Jaracz. (2007). Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis. Journal of Dermatological Treatment. 18(3). 151–157. 37 indexed citations
8.
Krueger, Gerald G., Lawrence F. Eichenfield, J. John Goodman, et al.. (2007). Pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adult and pediatric patients with moderate to severe atopic dermatitis.. PubMed. 6(2). 185–93. 23 indexed citations
9.
Chapman, Michael, Lawrence A. Schachner, Debra Breneman, et al.. (2005). Tacrolimus ointment 0.03% shows efficacy and safety in pediatric and adult patients with mild to moderate atopic dermatitis. Journal of the American Academy of Dermatology. 53(2). S177–S185. 40 indexed citations
10.
Paller, Amy S., Mark Lebwohl, Alan B. Fleischer, et al.. (2005). Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: Results from 3 randomized, comparative studies. Journal of the American Academy of Dermatology. 52(5). 810–822. 93 indexed citations
11.
Schachner, Lawrence A., Cindy L. Lamerson, Mary P. Sheehan, et al.. (2005). Tacrolimus Ointment 0.03% Is Safe and Effective for the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Patients: Results From a Randomized, Double-Blind, Vehicle-Controlled Study. PEDIATRICS. 116(3). e334–e342. 65 indexed citations
12.
Stiehm, E. Richard, Robert L. Roberts, Michael Kaplan, et al.. (2005). Pneumococcal seroconversion after vaccination for children with atopic dermatitis treated with tacrolimus ointment. Journal of the American Academy of Dermatology. 53(2). S206–S213. 35 indexed citations
13.
Koo, John, Alan B. Fleischer, William Abramovits, et al.. (2005). Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: Results in 8000 patients. Journal of the American Academy of Dermatology. 53(2). S195–S205. 57 indexed citations
14.
Hanifin, Jon M., Amy S. Paller, Lawrence F. Eichenfield, et al.. (2005). Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis. Journal of the American Academy of Dermatology. 53(2). S186–S194. 98 indexed citations
15.
Naylor, Mark F., et al.. (2005). Non‐melanoma skin cancer in patients with atopic dermatitis treated with topical tacrolimus. Journal of Dermatological Treatment. 16(3). 149–153. 39 indexed citations
16.
Fleischer, Alan B., Mark Ling, Lawrence F. Eichenfield, et al.. (2002). Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infections. Journal of the American Academy of Dermatology. 47(4). 562–570. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathalie Barbier Breakdown of academic impact, for papers by Zbigniew Samochocki Breakdown of academic impact, for papers by Jeremy Udkoff Breakdown of academic impact, for papers by Michelle Tarbox Breakdown of academic impact, for papers by Ann Broberg Breakdown of academic impact, for papers by Claudia Jenneck Breakdown of academic impact, for papers by Matthias Braeutigam Breakdown of academic impact, for papers by Natalija Novak Breakdown of academic impact, for papers by Murlidhar Rajagopalan Breakdown of academic impact, for papers by May E. Venturanza
Rankless by CCL
2026